Information Collection Request

The National Physician Survey of Precision Medicine in Cancer Treatment (NCI)

ICR 201602-0925-012 · OMB 0925-0739 · Historical Active

Forms and Documents
DocumentTypeStatusAvailability
Form 4 Telephone Reminder Script Form and Instruction New Repair queued
Form 3 Non-response Follow-back Survey Form and Instruction New Repair queued
Form 2 Precision Medicine Survey Full Study Form and Instruction New Available
Form 2 Precision Medicine Survey Pilot Study Form and Instruction New Available
Form 1 Telephone Screener Form and Instruction New Available
Precision 30-Day FRN.pdf Supplementary Document Uploaded 2016-02-26 Repair queued
Attachment I Privacy Act Memo.pdf Supplementary Document Uploaded 2016-02-22 Available
Attachment H OHSRP Exemption.pdf Supplementary Document Uploaded 2016-02-22 Available
AttachG.References.docx Supplementary Document Uploaded 2016-02-22 Available
AttachF_Consultants.doc Supplementary Document Uploaded 2016-02-22 Available
AttachC_CoverLetters.docx Supplementary Document Uploaded 2016-02-22 Repair queued
SSB Precision Medicine Final.docx Supporting Statement B Uploaded 2016-05-12 Available
SSA Precision Medicine Final.docx Supporting Statement A Uploaded 2016-05-12 Available
IC Document Collections
IC IDCollectionTypeStatusForm
220191 Telephone Reminder Script Form and Instruction New
220189 Non-response Follow-back Survey Form and Instruction New
220187 Precision Medicine Survey Full Study Form and Instruction New
220184 Precision Medicine Survey Pilot Study Form and Instruction New
220183 Telephone Screener Form and Instruction New
ICR Details
0925-0739 201602-0925-012
Historical Active
HHS/NIH
The National Physician Survey of Precision Medicine in Cancer Treatment (NCI)
New collection (Request for a new OMB Control Number)   No
Regular
Approved with change 05/12/2016
Retrieve Notice of Action (NOA) 03/01/2016
  Inventory as of this Action Requested Previously Approved
05/31/2018 24 Months From Approved
2,190 0 0
350 0 0
0 0 0

The purpose of this study is to investigate the current practice of precision medicine in cancer treatment among medical oncologists in the U.S. This is a nationally representative survey designed to assess oncologists’ current and potential use of genomic testing, to inform the development of interventions to facilitate optimal use of genomic testing and to improve patient-physician discussions of the risks, possible benefits, and uncertainties surrounding the use of these tests. Current knowledge of this topic is limited as there are no nationally-representative studies on this topic to date.

US Code: 42 USC sect 285 Name of Law: Public Health Service Act
  
None

Not associated with rulemaking

  80 FR 72077 11/18/2015
81 FR 9869 02/26/2016
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 2,190 0 0 2,190 0 0
Annual Time Burden (Hours) 350 0 0 350 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a new submission.

$368,520
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
Tawanda Abdelmouti 240 276-5530 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
03/01/2016